No Data
No Data
Asieris Signs Supply Deal With US CDC for Free-Living Amoeba Infection Treatment
Express News | A restricted stock worth 0.199 billion yuan is unlocked today, with Xiamen Tungsten, Yanhong Pharmaceutical-U, and Verisilicon Microelectronics (Shanghai) Co., Ltd. having the largest market capitalizations released.
Yahong Medical (688176.SH) approximately 6.8005 million restricted shares will be listed and circulated starting from January 7.
Yahong Pharmaceutical (688176.SH) announced that the restricted shares for this listing circulation are from the company's initial public offering prior to...
Asia Rainbow Pharmaceuticals (688176.SH): Shareholder voluntarily commits to extend the lock-up period of shares.
Gelonghui, on December 27, announced that Yahong Pharmaceuticals (688176.SH) received a letter of commitment from its Shareholder regarding the voluntary extension of the lock-up period for restricted shares. Based on the confidence in the company's future development prospects and recognition of its investment value, the company's controlling Shareholder and actual controller, Mr. PANKE, along with his concerted action parties Pan-Scientific Holdings Co., Ltd., Taizhou Donghong Enterprise Management Center (Limited Partnership), and Taizhou Yahong Enterprise Management Center (Limited Partnership), a total of three Shareholders, have committed to lock up all the shares they Hold before the company's initial public offering.
Yahong Meditech Says Cervical Lesion Drug Trial Shows Good Results
Express News | Yahong Medicine: APL-1702 clinical trial data selected for the 2024 International Papillomavirus Conference.
No Data